OncLive | MSK's CAR Trials Halted Temporarily Amid Safety Review OncLive Six of these patients relapsed or were refractory to treatment, and two more died from complications that arose from allogeneic bone marrow transplantation, to which patients were transitioned after CAR therapy. The 2 patients whose deaths prompted the ... |
